| HDAC inhibitors |
Status of Clinical trial |
| JNJ26481585 |
Preclinical |
| Dacinostat |
Preclinical |
| Belinostat (PXD101) |
Phase II |
| Resminostat (4SC-201) |
Phase II |
| Panobinostat |
Phase III |
| Etinostat |
Phase II |
| Vornistat(SAHA); Zolina |
Completed; US FDA approved (2007) |
| Romidepsin |
Completed; US FDA 2009 |
|
